Long-term follow-up after switching from originator infliximab to its biosimilar CT-P13: the weight of nocebo effect.

Autor: Germain, Vincent, Scherlinger, Marc, Barnetche, Thomas, Schaeverbeke, Thierry, Fédération Hospitalo-universitaire ACRONIM
Zdroj: Annals of the Rheumatic Diseases; Jan2020, Vol. 79 Issue 1, p1-2, 2p, 1 Graph
Databáze: Complementary Index